Berman Capital Advisors LLC acquired a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 540 shares of the medical research company’s stock, valued at approximately $120,000.

Other institutional investors also recently made changes to their positions in the company. Archford Capital Strategies LLC lifted its holdings in shares of Thermo Fisher Scientific by 0.9% in the fourth quarter. Archford Capital Strategies LLC now owns 4,610 shares of the medical research company’s stock valued at $1,032,000 after purchasing an additional 43 shares in the last quarter. Aries Wealth Management lifted its holdings in shares of Thermo Fisher Scientific by 1.1% in the fourth quarter. Aries Wealth Management now owns 4,269 shares of the medical research company’s stock valued at $955,000 after purchasing an additional 45 shares in the last quarter. Balasa Dinverno & Foltz LLC lifted its holdings in shares of Thermo Fisher Scientific by 2.1% in the fourth quarter. Balasa Dinverno & Foltz LLC now owns 2,238 shares of the medical research company’s stock valued at $501,000 after purchasing an additional 46 shares in the last quarter. Atlas Capital Advisors LLC lifted its holdings in shares of Thermo Fisher Scientific by 5.5% in the fourth quarter. Atlas Capital Advisors LLC now owns 923 shares of the medical research company’s stock valued at $207,000 after purchasing an additional 48 shares in the last quarter. Finally, Johnson Financial Group Inc. lifted its holdings in shares of Thermo Fisher Scientific by 8.0% in the fourth quarter. Johnson Financial Group Inc. now owns 673 shares of the medical research company’s stock valued at $151,000 after purchasing an additional 50 shares in the last quarter. 87.11% of the stock is owned by institutional investors and hedge funds.

In related news, insider Gregory J. Herrema sold 3,299 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $263.05, for a total transaction of $867,801.95. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Peter E. Hornstra sold 5,920 shares of the company’s stock in a transaction dated Friday, February 15th. The stock was sold at an average price of $250.00, for a total value of $1,480,000.00. Following the sale, the chief accounting officer now owns 17,057 shares in the company, valued at approximately $4,264,250. The disclosure for this sale can be found here. Insiders have sold 36,927 shares of company stock worth $9,388,124 in the last quarter. 0.49% of the stock is currently owned by corporate insiders.

A number of analysts have recently commented on TMO shares. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $270.00 price target on the stock in a report on Monday, November 19th. BTIG Research boosted their price target on Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a report on Thursday, January 31st. Finally, Robert W. Baird boosted their price target on Thermo Fisher Scientific from $264.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Thermo Fisher Scientific currently has a consensus rating of “Buy” and a consensus target price of $275.70.

TMO opened at $263.09 on Friday. Thermo Fisher Scientific Inc. has a 52-week low of $199.85 and a 52-week high of $266.18. The stock has a market cap of $104.97 billion, a P/E ratio of 23.66, a P/E/G ratio of 1.68 and a beta of 1.13. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.23 and a current ratio of 1.73.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.19 by $0.06. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The business had revenue of $6.51 billion for the quarter, compared to analyst estimates of $6.26 billion. During the same quarter in the prior year, the company posted $2.79 earnings per share. Thermo Fisher Scientific’s revenue was up 7.6% on a year-over-year basis. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 12.14 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 16th. Investors of record on Friday, March 15th will be issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.29%. The ex-dividend date is Thursday, March 14th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. Thermo Fisher Scientific’s dividend payout ratio is presently 6.12%.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/berman-capital-advisors-llc-acquires-shares-of-540-thermo-fisher-scientific-inc-tmo/2896289.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Read More: Average Daily Trade Volume – What It Means In Stock Trading

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.